LH10 is an FXR agonist based on fexaramine, with an EC50 of 0.14 µM. It offers hepatoprotective effects, mitigating conditions such as cholestasis induced by alpha naphthylisothiocyanate (ANIT), acute liver injury caused by APAP, and non-alcoholic steatohepatitis (NASH).
Molecular Weight:
515.64
Formula:
C34H33N3O2
Target:
FXR
* VAT and and shipping costs not included. Errors and price changes excepted
